Silkim Pharma

Developing a novel platform of non-steroidal chemical complexes for treating multiple indications.

Health Tech & Life Sciences
Active
Mature Tel Mond, Israel Founded 2013
Last updated 2026-07-22
Total raised
$3.2M
Stage
Mature
Founded
2013
Headcount
1
HQ
Tel Mond, Israel
Sector
Health Tech & Life Sciences

About

Silkim Pharma is an Israeli startup developing a novel, protected platform of non-steroidal chemical complexes for the treatment of multiple indications. The platform, derived from IP created at the Hebrew University and Hadassah Hospital, utilizes two families of non-steroidal chemical complexes with components approved for clinical use. These New Chemical Entities offer three synergistic mechanisms of action: anti-inflammatory, iron chelating, and anti-biotic, which have been extensively tested in animal models of human diseases. The company's subsidiary, Concenter Biopharma Ltd., is currently entering clinical trial Phase 2a at the Sheba Medical Center, focusing on developing oral drugs for Type 2 Diabetes. Potential clinical applications also include CNS degenerative diseases, inflammatory skin disorders, and inflammatory pulmonary diseases.

Funding history · 3 rounds · $3.2M total

2026-01
Equity crowdfunding $1.2M PitchBook, Startup Nation Finder
★ ExitValley
2020-09
Equity crowdfunding $1.2M Startup Nation Finder
★ PipelBiz
2016-05
Undisclosed Round $2.0M Startup Nation Finder

Headcount over time

From 6 (2020-07) to 1 (2024-08) · -5 (-83%) · 2 points · source: Finder history + radar grounding
60 2020-07 2024-08

Q&A

What is Silkim Pharma's primary focus?
Silkim Pharma focuses on developing novel drugs that target inflammatory pathologies.
When was Silkim Pharma founded?
Silkim Pharma was founded in March 2013.
What is the current employee count for Silkim Pharma?
Silkim Pharma has 1-10 employees.
What is Silkim Pharma's primary sector classification?
Silkim Pharma's primary sector is Health Tech & Life Sciences.
What kind of platform has Silkim Pharma developed?
Silkim Pharma has developed a novel, protected platform of drugs for treating multiple indications, based on extensive investigation of animal models of human diseases.
What are the key actions of Silkim Pharma's drug platform members?
Members of Silkim Pharma's platform act as potent anti-inflammatory agents, strong iron-chelating agents, and antibiotic agents.
Does Silkim Pharma hold any patents?
Yes, Silkim Pharma holds 1 patent.

Team · 2

Dror Chevion
Founder · Co-founder & CEO
Prof. Mordechai (Mottie) Chevion
Founder · Co-founder & CSO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 PatentsVerified

Tags

drug-developmentinflammatory-diseasesdegenerative-diseasestreatmentspharmaceuticalsdrug-discoverycrohn-s-diseasediabetesanti-inflammatory
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitesilkim.com/
LinkedInlinkedin.com/company/35704086
Facebookfacebook.com/SilkimPharma

Identifiers & details

Legal nameSILKIM PHARMA LTD
Founded2013-3
Employees (exact)1

Radar intelligence

Patents

EPO1

Web history (Wayback)

Domainsilkim.com

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)514894195
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2013-03-04
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2026
Active charges / liens0
Registry events3 — violation (2), annual_report (1)
Registered addressהיהלום 18 תל מונד

Recent registry events

DateEvent
2026-06-25עדכון הפרה
2026-06-16דו~ח שנתי-עדכון מען דיגיטלי
2025-12-07עדכון הפרה